Skip to content
  • KOSPI 2577.27 -2.21 -0.09%
  • KOSDAQ 722.52 -7.07 -0.97%
  • KOSPI200 341.49 +0.02 +0.01%
  • USD/KRW 1396 -2.00 0.14%
View Market Snapshot

Deals

Mergers & Acquisitions

Proxy advisor KCGS backs Hanmi founder's sons return to board

South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group’s late founder's two sons in their bid to return as board members of the group’s holding firm

Mar 20, 2024 (Gmt+09:00)

3 Min read